These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 20868881)
1. Assessment and treatment of movement disorders in children with cerebral palsy. Deon LL; Gaebler-Spira D Orthop Clin North Am; 2010 Oct; 41(4):507-17. PubMed ID: 20868881 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of spasticity in children with cerebral palsy. Verrotti A; Greco R; Spalice A; Chiarelli F; Iannetti P Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270 [TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin type A in the treatment plan for cerebral palsy]. Strobl W Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of spasticity in cerebral palsy with botulinum toxin]. Calderón-González R; Calderón-Sepúlveda RF Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892 [TBL] [Abstract][Full Text] [Related]
5. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. Hawamdeh ZM; Ibrahim AI; Al-Qudah AA Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Gibson N; Graham HK; Love S Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606 [TBL] [Abstract][Full Text] [Related]
7. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy. Park ES; Rha DW; Lee JD; Yoo JK; Chang WH Neuropediatrics; 2009 Dec; 40(6):269-74. PubMed ID: 20446220 [TBL] [Abstract][Full Text] [Related]
8. [Transition from childhood to adulthood and management of spasticity]. Roujeau T; Di Rocco F; Zérah M Neurochirurgie; 2008 Oct; 54(5):618-20. PubMed ID: 18809186 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of childhood spasticity secondary to cerebral palsy using Botox. Gill C; Covington C; Padaliya B; Newman W; Pomeroy T; Charles PD Tenn Med; 2003 Nov; 96(11):511-3. PubMed ID: 14635360 [TBL] [Abstract][Full Text] [Related]
10. [The influence of permanent cerebellar stimulation on senso-motor disorders in cerebral palsy (author's transl)]. Winkelmüller W; Seidel BU; Dietz H Neurochirurgia (Stuttg); 1977 Nov; 20(6):179-85. PubMed ID: 304185 [TBL] [Abstract][Full Text] [Related]
11. [Clinical treatment (non surgical) of spasticity in cerebral palsy]. Calderón-González R; Calderón-Sepúlveda RF Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886 [TBL] [Abstract][Full Text] [Related]
18. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402 [TBL] [Abstract][Full Text] [Related]
19. Management of spasticity in children with cerebral palsy. Tilton A Semin Pediatr Neurol; 2009 Jun; 16(2):82-9. PubMed ID: 19501336 [TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]